$ TAXMAN

: :

Call MEDISCA now at 1-800-932-1039 1-800-932-1039

Beyond-Use Date Databank - Topical Bases




= Controlled substance in US and Canada

FORMULA
NUMBER
APIBASEBUD
F 008 219 Amitriptyline HCl 10% PLO Gel Mediflo 30 (Pre-Mixed) 90 days
F 004 661 Amitriptyline HCl 2%, Cyclobenzaprine HCl 0.5%, Piroxicam 0.5% PLO GEL MEDIFLO™ (Pre-Mixed) 90 Days at RT
F 004 517 Baclofen 2% PLO GEL MEDIFLO™ (Pre-Mixed) 90 Days
F 008 302 Baclofen 2%, Cyclobenzaprine HCl 2%, Diclofenac Na 3%, Lidocaine HCl 2%, Ketoprofen 10% TRANSDERMAL PAIN BASE 60 days at RT
F 004 522 Baclofen 5% PLO GEL MEDIFLO™ 30 (Pre-Mixed) 90 Days
F 004 035 Benzocaine 20% VERSAPRO™ CREAM BASE 60 Days
F 004 690 Benzocaine 20%, Lidocaine HCl 6%, Phenylephrine HCl 0.01%, Tetracaine HCl 4% PENDERM™ CREAM BASE 30 Days
F 004 907 Citric Acid 3% VERSAPRO™ GEL BASE 90 Days
F 004 687 Clonidine HCl 0.23% VANISH-PEN™ CREAM BASE 90 Days
F 004 790 Cyclobenzaprine HCl 1% PENDERM™ CREAM BASE 90 Days at 4oC
F 004 036 Cyclobenzaprine HCl 1% VERSAPRO™ CREAM BASE 60 Days
F 004 542 DHEA (Dehydro-Epi-Andosterone) 2% HRT CREAM BASE 90 Days
F 004 521 Diclofenac Sodium 10% PLO GEL MEDIFLO™ 30 (Pre-Mixed) 90 Days
F 006 428 Diclofenac Sodium 10% VERSAPRO™ GEL BASE 90 Days
F 004 518 Diclofenac Sodium 2% PLO GEL MEDIFLO™ (Pre-Mixed) 90 Days
F 008 342 & F 008 332 Estradiol 0.01%-10% (Bracketed) HRT CREAM BASE 180 days at RT
F 008 341 & F 008 331 Estriol 0.01%-10% (Bracketed) HRT CREAM BASE 180 days at RT
F 001 243v2 Estriol 0.2%, Estradiol 0.025%, Estrone 0.025% HRT CREAM BASE 90 Days
F 004 029 Estriol 0.4%, Estradiol 0.1%, Progesterone 4% VERSAPRO™ CREAM BASE 60 Days
F 004 689 Fluconazole 2%, Ibuprofen 2% VANISH-PEN™ CREAM BASE 90 Days
F 004 794 Gabapentin 6% PLO GEL MEDIFLO™ 30 (Pre-Mixed) 30 Days at RT
F 004 792 Gabapentin 6% VERSAPRO™ CREAM BASE 60 Days
F 004 030 Hydrocortisone 2% VERSAPRO™ CREAM BASE 60 Days
F 004 906 Hydroquinone 2%, Kojic Acid 4%, Tretinoin 0.025% VERSAPRO™ GEL BASE 30 Days
F 004 684 Ketamine HCl 11.5% VANISH-PEN™ CREAM BASE 60 Days
F 004 695 Ketamine HCl 8.625% VERSAPRO™ CREAM BASE 60 Days
F 004 691 Ketoprofen 10% PENDERM™ CREAM BASE 90 Days
F 004 730 Ketoprofen 10% PLO TRANSDERMAL CREAM 60 Days at 4oC
F 004 533 Ketoprofen 10% VERSAPRO™ CREAM BASE 90 Days at 4oC
F 004 908 Lactic Acid 2% VERSAPRO™ GEL BASE 90 Days
F 004 031 Lidocaine HCl 5% VERSAPRO™ CREAM BASE 60 Days
F 004 520 Metoclopramide HCl 1.5% PLO GEL MEDIFLO™ (Pre-Mixed) 90 Days
F 004 524 Metoclopramide HCl 2.4% PLO GEL MEDIFLO™ 30 (Pre-Mixed) 90 Days
F 008 208 Minoxidil 2%-5.5% (Bracketed) FOAMIL 180 days at RT
F 008 224 Minoxidil 6%-15% (Bracketed) FOAMIL 180 days at RT
F 004 523 Naproxen 20% PLO GEL MEDIFLO™ 30 (Pre-Mixed) 90 Days
F 004 519 Naproxen 5% PLO GEL MEDIFLO™ (Pre-Mixed) 90 Days at RT
F 004 688 Pentoxifylline 5% VANISH-PEN™ CREAM BASE 90 Days
F 002 488 Progesterone 10% HRT CREAM BASE 60 Days
F 001 697 Progesterone 10% PLO TRANSDERMAL CREAM 60 Days
F 004 682 Progesterone 10% VANISH-PEN™ CREAM BASE 90 Days
F 004 904 Progesterone 15% VERSAPRO™ GEL BASE 90 Days
F 004 303 Selegiline HCl 1% VANISH-PEN™ CREAM BASE 30 Days
F 004 905 Sodium Bicarbonate 2% VERSAPRO™ GEL BASE 90 Days
F 001 539 Testosterone 1% HRT CREAM BASE 90 Days
F 004 540 Testosterone 1% VERSAPRO™ CREAM BASE 90 Days
F 004 903 Testosterone 10% VERSAPRO™ GEL BASE 90 Days
F 004 034 Tetracaine HCl 4% VERSAPRO™ CREAM BASE 60 Days
F 004 436v2 Tramadol HCl 5% PENDERM™ CREAM BASE 30 Days at RT
F 004 731 Verapamil HCl 15% PLO TRANSDERMAL CREAM 30 Days
F 004 685 Verapamil HCl 15% VANISH-PEN™ CREAM BASE 30 Days
NOTE : When room temperature (RT) or 4oC are not specified, preparation is stable at both temperatures.
DISCLAIMER: This data is provided for informational purposes only, representing the results of a study of the product stability with various active pharmaceutical ingredients. For further information on packaging, please refer to the actual formula. This document does not serve, and may not be construed, as a representation or guarantee of product performance. In all cases the practitioner is advised to consult recognized pharmaceutical compendia and other recognized sources for product formulation and other product characteristics, including stability. MEDISCA and its affiliates make no warranties or representations with regards to the functioning or appropriateness of this product in anycompounded formulation, the use of which is solely at the discretion and liability of the practitioner. It is the responsibility of the pharmacist or other appropriately state licensed professional to verify the accuracy and validity of the information contained herein, with regards to scheduling, federal and state/provincial laws allowing the use of the formulas, products and final compounds in the country of use.
X

We have placed cookies on your device to help make this website better.

We also use cookies to collect information for making reports and to help us improve the site. The cookies collect information in an anonymous form.



Copyright® 1989-2019 Medisca Inc.
All rights reserved

MEDISCA is ISO 9001:2008 certified MEDISCA is a proud VAWD-accredited facility